Abstract
Anthracyclines, such as doxorubicin, remain a key component of many chemotherapy regimens in pediatric and adult malignancies. Cardiovascular disease remains the leading cause of morbidity and mortality among patients treated with anthracycline. The mechanism of anthracycline -induced heart damage is incompletely understood, but consists, in part, of generation of reactive oxygen species…